Deutsche Bank (DE:DBKGn) analyst Imron Zafar maintained a Hold rating on Intuitive Surgical (NASDAQ:ISRG) on Tuesday, setting a price target of $825, which is approximately 1.71% below the present share price of $839.38.
Zafar expects Intuitive Surgical to post earnings per share (EPS) of $3.61 for the second quarter of 2021.
The current consensus among 15 TipRanks analysts is for a Moderate Buy rating of shares in Intuitive Surgical, with an average price target of $885.83.
The analysts price targets range from a high of $953 to a low of $825.
In its latest earnings report, released on 03/31/2021, the company reported a quarterly revenue of $1.29 billion and a net profit of $416.8 million. The company's market cap is $99.39 billion.
According to TipRanks.com, Deutsche Bank analyst Imron Zafar is currently ranked with 3 stars on a 0-5 stars ranking scale, with an average return of 19.2% and a 87.50% success rate.
Intuitive Surgical, Inc. manufactures and develops robotic-assisted products, most notably with the da Vinci surgical system and related instruments and accessories, to improve clinical outcomes of patients through minimally invasive surgery. Its products include Da Vinci and Ion. The company was founded in 1995 and is headquartered in Sunnyvale, California.